Author Archives: Paul Rector

A running theme at the Asembia 2017 Specialty Pharmacy Summit was the explosive growth in attendance from several hundred a few years ago to greater than 6,000 in attendance in 2017.  Pharmaceutical and Biological (Pharma/Bio) manufacturers were the dominant presence at Asembia, which is no surprise given their pricing power in the specialty drug market, […]

Setting a familiar tone for the Specialty Drug landscape, the presentation by Express Scripts during AMCP’s opening session (Speaker: Aimee Tharaldson, PharmD) included staggering cost increases within both the medical and pharmacy benefit, however encouraging news of emerging treatments.  Beyond that “given” (and the fact that oncolytics represent their industry), here are ten (10) observations worth […]

Having personally dismissed 99% of these CEO missives, I wrestled with the need, never-mind the value of this communication. My objective since taking the reins of RJ Health Systems in 2015 has largely been to distinguish us from the jargon-filled, oftentimes frenzied industry heavyweights we operate alongside in service to Payors and Providers in the […]

  What does it take to ensure sound reimbursement policies on physician administered drugs?  In a phrase, it takes “good data.” We, at RJ Health Systems, consider our data to be the industry standard for evaluating Medical drug reimbursement policy – a position we’ve earned over the past 16-years (average customer tenure is a whopping […]

To Our Valued Customers: 2015 was an unbelievable year of growth for RJ Health, and we cannot thank you and your organization enough for being a part of our journey. We spent the year side-by-side with many of you in order to capture your “voice” and define our product roadmap. Here are five trends we […]

The Magellan Rx Management Specialty Summit was held recently in New York City. RJ Health Systems’ very own Paul Rector was in attendance listening and connecting with thought leadership in the specialty drug space. Nationally-recognized payors, oncologists, and industry leaders explored and discussed the key issues, challenges and emerging trends facing an evolving specialty market […]